You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
14 August 2025 - India-based global pharmaceutical company Shilpa Medicare Limited (BSE:530661, NSE:SHILPAMED) announced on Thursday that it has obtained the world's first regulatory approval for Nor Ursodeoxycholic Acid (NorUDCA) Tablets - a dr...
14 August 2025 - Nanjing Leads Biolabs Co, Ltd (9887.HK) announced on Thursday that it has completed patient enrollment in its pivotal single-arm registrational trial (CTR20213023) evaluating Opamtistomig (LBL-024) monotherapy for extrapulmonary neur...
14 August 2025 - US-based Maxor Specialty Pharmacy, a VytlOne company, and a pharmacy solutions partner, announced on Wednesday that it has been selected by New Jersey-based biotech company Insmed to be a limited distribution provider of Brinsupri.Br...
14 August 2025 - Remegen (688331.SH/09995.HK), a China-based pharmaceutical company, announced on Wednesday that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, Telitacicept, met the primary endpoint in its Phase III clin...
14 August 2025 - BioDlink, a China-based pharmaceutical company, announced on Wednesday that its self-developed bevacizumab injection biosimilar has received marketing approval from Colombia's National Institute for Surveillance of Medicines and...
13 August 2025 - Norwegian pharmaceutical company Navamedic ASA (OSE:NAVA) said on Wednesday that it has obtained final approval for packaging materials for Flexilev in OraFID in national languages for Norway, Sweden, and Denmark, completing the regu...
13 August 2025 - PainReform Ltd (Nasdaq:PRFX), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, said on Wednesday that it has acquired a majority equity interest in LayerBio Inc, a privately ...